[FOR IMMEDIATE RELEASE: November 10, 2023] Vancouver, B.C. – Lab 915 Technologies Inc. is meeting the challenge of bringing new technologies to the assistive device market through the completion of a project in collaboration with British Columbia Institute of Technology’s Centre for Applied Research and Innovation MAKE+ Group, internship via Simon Fraser University, and funding support via Mitacs.
Working to address the innovation gap, the company is developing promising new products with life-
changing implications for people who suffer from plantar fasciitis and achilles tendinopathy.
Affecting more than 15% of the general population, plantar fasciitis and achilles tendinopathy have
significant effect on health and wellbeing including occupational, physical, and mental health. Through
development and innovation, there is an opportunity to advance assistive device medical technology to
improve treatment outcomes and ultimately improve the health and well-being of Canadians.
“Mitacs has provided us access to resources, access to talent, and access to that additional R&D layer”,
says Jolanda Peters, Founder, Lab 915 Technologies Inc. “This collaboration project has enabled Lab 915
to move rapidly up the Technology Readiness Level scale in our goal to commercialize treatment
solutions that deliver value and benefit.”
About Lab 915 Technologies Inc.
Lab 915 Technologies Inc. is a female-founded, early-stage Vancouver-based start-up working on a novel
solution to solve the problems associated with assistive devices and the treatment of plantar fasciitis
and/or achilles tendinopathy. Based on personal experience with a family member and the adaptation
of an inventive orthopedic solution, the mission is to make the world a better place by enabling people
to return more quickly and easily to the activities they love. Lab 915 is a SFU Venture Connection
company, NRC IRAP partner beneficiary, Mitacs research collaborator.